Nutritional imbalance is common in patients with metabolic diseases. The iodine supply draws attention among the nutritional factors affecting the metabolic profile. The aim of the work was to evaluate the effect of the drink enriched with iodine and hydrogen on iodine supply in patients with metabolic syndrome (MetS). Nutrition was assessed in 107 persons with MetS, 40 of them (aged 59.5 (56.3–65) years) were included in the interventional study with “Vodis” drink enriched with iodine and hydrogen. The level of thyrotropin, thyroid hormones, thyroglobulin and antibodies to it in the blood serum were measured. Sonography of the thyroid gland was performed. Patients of the main group (20 people) received the drink “Vodis” in the amount of 990 ml per day (divided into three doses) for two months. Patients of the control group (20 people) – received drinking water, the base for the drink “Vodis”. An imbalance in the nutrition of patients with MetS is characterized by increased consumption of fat – from 37,7 to 44,4 % of the daily energy intake and a deficiency of some micronutrients. The intake of zinc, cobalt and vitamins – retinol, beta-carotene, vitamin D, thiamine and folic acid was insufficient. Iodine intake was 38–50 % of recommended and the highest intake was in males of middle age 74,4 (44,3–101,7) μg per day. The interventional study revealed an increased content of serum thyroglobulin (more than 13 μg / l) in 30 % of the patients, which reflects insufficient iodine intake. Higher baseline thyroid volume was associated with increased thyroglobulin level. The use of the drink enriched with iodine and hydrogen was accompanied by a decrease in the thyroglobulin level (p = 0.002) in the absence of changes in the thyroid gland volume and the level of thyroid panel hormones. Patients with MetS had unbalanced consumption of macronutrients and micronutrients that are important for the thyroid gland functioning. Median iodine intake was 38–50 % of the recommended level. The decrease of the serum thyroglobulin in patients with MetS who consumed the “Vodis” drink indicates an improvement in the iodine supply.

Article recieved: 13.07.2021

Keywords: metabolic syndrome, thyroid gland, iodine, thyroglobulin, Vodis

Full text: PDF (Ukr) 757K

1. 1. Noncommunicable diseases country profiles 2018. Geneva: World Health Organization; 2018: 222 p.
2. 2. Lapik IA, Galchenko AV, Gapparova KM. Micronutrient status in obese patients: A narrative review.Obesity Medicine. 2020; 18:100224.
3. 3. da Cunha ATO, Pereira HT, de Aquino SLS et al. Inadequacies in the habitual nutrient intakes of patients with metabolic syndrome: a cross-sectional study. Diabetol Metab Syndr. 2016;8:32.
4. 4. Goncalves A, Amiot MJ. Fat-soluble micronutrients and metabolic syndrome. Curr Opin Clin Nutr Metab Care. 2017;20(6):492-7.
5. 5. Kern HJ, Mitmesser SH. Role of nutrients in metabolic syndrome: a 2017 update. Nutrition and Dietary Supplements. 2018;10:13-26.
6. 6. Motamed S, Ebrahimi M, Safarian M, et al. Micronutrient intake and the presence of the metabolic syndrome. N Am J Med Sci. 2013;5(6):377-85.
7. 7. Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94(2):355-82.
8. 8. Тронько МД, Кравченко ВІ. Значення йоду для організму, найбільш вагомі його дослідження та перспективи запровадження йодної профілактики в Україні. Ендокринологія. 2021;26(1):59-73. DOI: 10.31793/1680-1466.2020.26-1.59. (Tronko MD, Kravchenko VI. The importance of iodine for the body, its most important research and prospects of introduction for iodine prevention in Ukraine. Endokrynologia. 2021; 26 (1): 59-73.
9. 9. Дідушко ОМ. Вікові особливості ліпідного обміну у хворих з маніфестним гіпотиреозом. Архів клінічної медицини. 2014; 1(20):21-3. Didushko OM. Аge features of lipid metabolism in patients with clinical hypothyroidism. Archive of Clinical Medicine. 2014; 1(20):21-3.
10. 10. Мітченко ОІ, Романов ВЮ, Гвоздик МВ. Ранні маркери атеросклерозу та серцево-судинний ризик у жінок із гіпертонічною хворобою на тлі гіпотиреозу. Ендокринологія. 2017;22(1):10-7. (Mitchenko O, Romanov V, Gvozdyk M. Early markers of atherosclerosis and cardiovascular risk in women with hypertensive disease against the background of hypothyroidism. Endokrynologia. 2017;22(1):10-7.)
11. 11. Журавльова ЛВ, Моїсеєнко ТА. Тиреоїдний статус у хворих на ожиріння різного ступеня. Ендокринологія. 2016;21(1):26-32. (Zhuravlyova L, Moyiseyenko T. Thyroid status in patients with obesity of different degree. Endokrynologia. 2016;21(1):26-32.)
12. 12. Al-Attas, O.S.; Al-Daghri, N.; Alkharfy, K.M.; Alokail, M.S.; Al-Johani, N.J.; Abd-Alrahman, S.H.; Yakout, S.M.;Draz, H.; Sabico, S. Urinary Iodine is Associated with Insulin Resistance in Subjects with Diabetes Mellitus Type 2.Exp. Clin. Endocrinol. Diabetes.2012;120: 618-22.
13. 13. Lee KW, Shin D, Song WO. Low Urinary Iodine Concentrations Associated with Dyslipidemia in US Adults. Nutrients. 2016;8(3):171.
14. 14. Herter-Aeberli I, Cherkaoui M, El Ansari N, Rohner R, Stinca S, Chabaa L, et al. Iodine Supplementation Decreases Hypercholesterolemia in Iodine-Deficient, Overweight Women: A Randomized Controlled Trial. J Nutr. 2015 Sep;145(9):2067-75.
15. 15. Asvold BO, Vatten LJ, Nilsen TI, Bjøro T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol. 2007;156(2):181-6.
16. 16. Li M, Zhang X, Zhou X, Han X, Zhang R, Fu Z, et al. The Association Between Serum Thyrotropin Within the Reference Range and Metabolic Syndrome in a Community-Based Chinese Population. Diabetes Metab Syndr Obes. 2020;13:2001-2011.
17. 17. Song B, Zuo Z, Tan J, Guo J, Teng W, Lu Y, Liu C. Association of thyroid nodules with adiposity: a community-based cross-sectional study in China. BMC Endocr Disord. 2018; 18(1):3.
18. 18. Ayturk S, Gursoy A, Kut A, Anil C, Nar A, Tutuncu NB. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol. 2009 Oct;161(4):599-605.
19. 19. Feng S, Zhang Z, Xu S, Mao X, Feng Y, Zhu Y, Liu C. The Prevalence of Thyroid Nodules and Their Association with Metabolic Syndrome Risk Factors in a Moderate Iodine Intake Area. Metab Syndr Relat Disord. 2017 Mar;15(2):93-7.
20. 20. Nakao A., Toyoda Y., Sharma P. et al. Effectiveness of Hydrogen Rich Water on Antioxidant Status of Subjects with Potential Metabolic Syndrome-An Open Label Pilot Study//J. Clin. Biochem. Nutr. 2010; 46: 140-149.
21. 21. Kajiyama S.., Hasegawa G., Asano M. et al. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance // Nutrition Research. 2008;28:137-143.
22. 22. Hong Y, Chen S, Zhang JM. Hydrogen as a selective antioxidant: a review of clinical and experimental studies// J Int Med Res. 2010;38(6):1893-903.
23. 23. Hashimoto M., Katakura M., Nabika T. et al. Effects of hydrogen-rich water on abnormalities in a SHR.Cg-Leprcp/NDmcr rat - a metabolic syndrome rat model.// Medical Gas Research. 2011.26: 1-6.
24. 24. Korovljev D., Trivic T., Drid P., OstojicS. M. Molecular hydrogen affects body composition, metabolic profiles, and mitochondrial function in middle-aged overweight women. Ir J Med Sci.2018;187:85.
25. 25. The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation. 2006.
26. 26. Карпенко ПО, Кириленко ЄК, Фус СВ, Мельничук НО. Спосіб розрахунку хімічного складу та енергетичної цінності раціонів харчування: інформаційний лист про нововведення. К.2012;378:2с. (Karpenko PО, Kyrylenko YeK, Fus SV., Melnychuk NO. The method of calculating of chemical composition and energy value of diets: newsletter about innovations. Kyiv. 2012;378:2p.)
27. 27. Кравченко ВІ. Йодний дефіцит як причина високої розповсюдженості тиреоїдної патології серед населення регіонів, що постраждали після аварії на ЧАЕС. Журн. НАМН України. 2016; 22(2): 222-9.(Kravchenko VI. Iodine deficiency as a cause of high prevalence of thyroid pathology in the population of regions affected by the Chernobyl accident. Zhurnal Nacional''noi' Akademii' Medychnyh Nauk Ukrai'ny. 2016; 22(2):222-9)
28. 28. Кравченко ВІ, Медведев БК. Біологічна роль йоду та йодна недостатність як патогенетичний фактор виникнення тиреоїдної патології у вагітних та її профілактика. Міжнародний ендокринологічний журнал. 2018; 14(2):111-8. (Kravchenko VI, Medvedev BK. The biological role of iodine and iodine deficiency as patogenetic factor of thyreoid pathology in pregnant women and its prevention. International Journal of Endocrinology. 2018;14(2):111-8). doi: org/10.22141/2224-0721.14.2.2018.130552
29. 29. Корзун ВН, Воронцова ТО, Антонюк ІЮ. Екологія і захворювання щитоподібної залози. Київ: Медінформ; 2018: 741 с. (Korzun VN, Vorontsova TO, Antoniuk IYu. Ecology and thyroid diseases. Kyiv: Medinform; 2018:741)
30. 30. Таращенко ЮМ, Коваленко АЄ, Кравченко ВІ, Ковзун ОІ, Сімуров ОВ. Йодо- та селенодефіцит у патогенезі зобної трансформації щитоподібної залози та автоімунних тиреопатій (огляд літератури та результати власних досліджень). Журн. Ендокринологія. 2020;25(4):297-304. (Tarashchenko YuМ, Kovalenko АYe, Kravchenko VІ, Kovzun OI, Simurov ОV. Iodine and selenium deficiency in the pathogenesis of goiter transformation of the thyroid gland and autoimmune thyropathies (literature review and results of own researches). J Endocrinol. 2020;25(4):297-304).
31. 31. Zimmermann MB. Interactions of vitamin A and iodine deficiencies: effects on the pituitary-thyroid axis. Int J Vitam Nutr Res. 2007 May;77(3):236-40.
32. 32. Benvenga S, Ferrari SM, Elia G, Ragusa F, Patrizio A, Paparo SR, et al. Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies. Nutrients. 2020 May 8;12(5):1337.
33. 33. Pałkowska-Goździk E, Lachowicz K, Rosołowska-Huszcz D. Effects of Dietary Protein on Thyroid Axis Activity. Nutrients. 2017;10(1):5.
34. 34. Fontana L, Klein S, Holloszy JO, Premachandra BN. Effect of long-term calorie restriction with adequate protein and micronutrients on thyroid hormones. J. Clin. Endocrinol. Metab. 2006; 91:3232-35.
35. 35. Remer T, Neubert A, Manz F. Increased risk of iodine deficiency with vegetarian nutrition. British Journal of Nutrition. 1999; 81(1):45-9.
36. 36. Zhang X, Chen W, Shao S, Xu G, Song Y, Xu C, et al. A High Fat Diet Rich in Saturated and Mono Unsaturated Fatty Acids Induces Disturbance of Thyroid Lipid Profile and Hypothyroxinemia in Male RatsMol. Nutr. Food Res. 2018 Mar;62(6):e1700599.
37. 37. Araujo RL, Andrade BM, Padrón AS, Gaidhu MP, Perry RLS, Carvalho DP, et al. High-Fat Diet Increases Thyrotropin and Oxygen Consumption without Altering Circulating 3,5,3′-Triiodothyronine (T3) and Thyroxine in Rats: The Role of Iodothyronine Deiodinases, Reverse T3 Production, and Whole-Body Fat Oxidation, Endocrinology. 2010;151(7):3460-9.
38. 38. Про затвердження Норм фізіологічних потреб населення України в основних харчових речовинах і енергії. Наказ МОЗ України № 1073 від 03.09.2017. (Norms of physiological needs of the Ukrainian population in the basic nutrients and energy. Order of the Ministry of Health of Ukraine № 1073 dated 03.09.2017) http (дата звернення 28.10.2020).
39. 39. Харченко НВ, Анохіна ГА, Бабак ОЯ та ін. Дієтологія. Київ: Меридіан, 2012. 527 с. (Kharchenko NV, Anokhina GA, Babak OYa et al. Dietology. Kyiv: Meridian; 2012:527)
40. 40. Manousou S, Stål M, Larsson C, Mellberg C, Lindahl B, Eggertsen R, et al. A Paleolithic-type diet results in iodine deficiency: a 2-year randomized trial in postmenopausal obese women. Eur J Clin Nutr. 2018;72(1):124-9.
41. 41. Severo JS, Morais JBS, de Freitas TEC, Andrade ALP, Feitosa MM, Fontenelle LC, et al. The Role of Zinc in Thyroid Hormones Metabolism. Int J Vitam Nutr Res. 2019 Jul;89(1-2):80-8.
42. 42. Khanam S. Impact of zinc on thyroid metabolism. J Diabetes Metab Disord Control. 2018; 5(1):27-8.
43. 43. Sanjari M, Gholamhoseinian A, Nakhaee A. The Association between Cobalt Deficiency and Endemic Goiter in School-Aged Children. Endocrinol Metab (Seoul). 2014 Sep;29(3):307-11.
44. 44. Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers. - 3rd ed.Geneva, World Health Organization, 2008. 97 p.
45. 45. Ma ZF, Skeaff SA. Thyroglobulin as a biomarker of iodine deficiency: a review. Thyroid. 2014; 24(8):1195-209.
46. 46. Bath SC, Pop VJ, Furmidge-Owen VL, Broeren MA, Rayman MP. Thyroglobulin as a Functional Biomarker of Iodine Status in a Cohort Study of Pregnant Women in the United Kingdom. Thyroid. 2017;27(3):426-33.
47. 47. Zimmermann MB1, Aeberli I, Andersson M, Assey V, Yorg JA, Jooste P, et al. Thyroglobulin is a sensitive measure of both deficient and excess iodine intakes in children and indicates no adverse effects on thyroid function in the UIC range of 100-299 μg/L: a UNICEF/ICCIDD study group report. J Clin Endocrin Metab. 2013 Mar;98(3):1271-80.
48. 48. Ma ZF, Venn BJ, Manning PJ, Cameron CM, Skeaff SA. Iodine Supplementation of Mildly Iodine-Deficient Adults Lowers Thyroglobulin: A Randomized Controlled Trial. J Clin Endocrinol Metab. 2016 Apr;101(4):1737-44.
49. 49. Кравченко ВІ, Березенко ВС, Сліпачук ЛВ, Лузанчук ІА, Голінько ОМ, Медведєв БК, Красніков ВІ. Йодне забезпечення дітей м. Київ. Ендокринологія. 2019;24(3):253-8. (Kravchenko V, Berezenko V, Slipachuk L, Luzanchuk I, Golin'ko O, Medvedev B, Krasnikov V. Iodine providing Kyiv children. Endokrynologia. 2019;24(3):253-8.)
50. 50. Chong W, Shi X, Shan Z, Teng X, Teng D, Guan H, et al. Tg in Adults as a Sensitive Biomarker of Iodine Status: A 5-Year Follow up Population Study in Different Levels of Iodine Intake Regions. PLoS One. 2015;10(8):e0135553.